Purchases and Sales Made in Q2 2023 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q2 2023. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-155K- 31.1% |
$13.4M - $15.6M
|
344K
$20.5M
|
|
|
Aug 14, 2023
Q2 2023
|
Rockefeller Capital Management L.P.
New York, NY |
SELL
|
- |
-177K- 24.26% |
$15.3M - $17.7M
|
553K
$33M
|
|
|
Aug 14, 2023
Q2 2023
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-190K- 61.93% |
$16.4M - $19M
|
117K
$6.95M
|
|
|
Jul 28, 2023
Q2 2023
|
Braun Stacey Associates Inc
|
SELL
|
- |
-194K- 50.84% |
$16.8M - $19.4M
|
187K
$11.2M
|
|
|
Aug 14, 2023
Q2 2023
|
Endurant Capital Management LP
San Mateo, CA |
SELL
|
- |
-212K- 82.94% |
$18.4M - $21.3M
|
43.6K
$2.6M
|
|
|
Aug 10, 2023
Q2 2023
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-216K- 93.77% |
$18.7M - $21.7M
|
14.4K
$856K
|
|
|
Aug 11, 2023
Q2 2023
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-218K- 77.08% |
$18.9M - $21.8M
|
64.8K
$3.86M
|
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-221K- 19.56% |
$19.2M - $22.2M
|
910K
$54.3M
|
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-260K- 25.7% |
$22.5M - $26M
|
750K
$44.8M
|
|
|
Feb 14, 2024
Q2 2023
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
SELL
|
- |
-389K- 89.23% |
$33.7M - $39M
|
47K
$2.8M
|
|
|
Aug 14, 2023
Q2 2023
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-410K- 60.89% |
$35.5M - $41.1M
|
263K
$15.7M
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-422K- 49.56% |
$36.5M - $42.3M
|
429K
$25.6M
|
|
|
Jul 18, 2023
Q2 2023
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-438K- 93.8% |
$37.9M - $43.9M
|
28.9K
$1.73M
|
|
|
Aug 14, 2023
Q2 2023
|
Man Group PLC
London, X0 |
SELL
|
- |
-451K- 61.77% |
$39.1M - $45.3M
|
279K
$16.7M
|
|
|
Aug 11, 2023
Q2 2023
|
Capital Research Global Investors
Los Angeles, CA |
SELL
|
- |
-453K- 6.28% |
$39.3M - $45.4M
|
6.76M
$403M
|
|
|
Aug 03, 2023
Q2 2023
|
Jennison Associates LLC
|
SELL
|
- |
-496K- 73.62% |
$43M - $49.8M
|
178K
$10.6M
|
|
|
Aug 14, 2024
Q2 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-583K- 16.11% |
$50.5M - $58.5M
|
3.04M
$181M
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-623K- 4.26% |
$54M - $62.5M
|
14M
$836M
|
|
|
Aug 14, 2023
Q2 2023
|
Amundi
Paris, I0 |
SELL
|
- |
-736K- 63.06% |
$63.8M - $73.8M
|
431K
$25.7M
|
|
|
Aug 11, 2023
Q2 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-833K- 45.84% |
$72.2M - $83.5M
|
984K
$58.7M
|
|
|
Aug 14, 2023
Q2 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-2.56MClosed |
$222M - $257M
|
0
$0
|